Home > Insider Trading > Filing (0001455244-10-000073)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Qlt Inc	QLTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1360509	Florian Schonharting	Ostergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No
1360573	Christian Hansen	Ostergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No
1451330	K/S Equity Public Nb	Ostergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares, No Par Value	Acquisiton	2010-03-16	1,267	$4.97	7,687,984	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-16	200	$4.97	7,688,184	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-16	300	$4.98	7,688,484	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-16	13,700	$4.98	7,702,184	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-16	100	$4.99	7,702,284	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-16	17,645	$4.99	7,719,929	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-16	7,684	$5.00	7,727,613	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners.
Christian Hansen and Florian Sch?nharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Sch?nharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein.